Rege Nephro
Contributing to society by researching and developing various solutions for kidney diseases and improving the quality of life of patients suffering from kidney diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
* |
| JPY22.5b | Series B |
| Total Funding | 000k | ||
Related Content
RegeNephro is a pioneering company specializing in the development of advanced treatments for renal diseases through regenerative medicine. The company serves healthcare providers, research institutions, and pharmaceutical companies, operating primarily in the biotechnology and healthcare markets. RegeNephro's business model focuses on research and development, leveraging proprietary technologies and patents to create innovative solutions for kidney disease treatment. Revenue is generated through partnerships, licensing agreements, and the commercialization of their medical solutions. The company aims to address the growing demand for effective renal disease treatments by utilizing cutting-edge science and technology.
Keywords: renal disease, regenerative medicine, biotechnology, healthcare, research, development, patents, partnerships, licensing, commercialization.